214 related articles for article (PubMed ID: 38690023)
1. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
Valibouze C; Dubuquoy C; Chavatte P; Genin M; Maquet V; Modica S; Desreumaux P; Rousseaux C
World J Gastroenterol; 2024 Apr; 30(16):2258-2271. PubMed ID: 38690023
[TBL] [Abstract][Full Text] [Related]
2. Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.
Wang FY; Su M; Zheng YQ; Wang XG; Kang N; Chen T; Zhu EL; Bian ZX; Tang XD
Acta Pharmacol Sin; 2015 Jun; 36(6):708-15. PubMed ID: 25960135
[TBL] [Abstract][Full Text] [Related]
3. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
[TBL] [Abstract][Full Text] [Related]
4. Calcium Pyruvate Exerts Beneficial Effects in an Experimental Model of Irritable Bowel Disease Induced by DCA in Rats.
Rodríguez-Nogales A; Algieri F; Vezza T; Garrido-Mesa J; Molina-Tijeras JA; Rodríguez-Cabezas ME; Utrilla MP; Pischel I; Gálvez J
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30634696
[TBL] [Abstract][Full Text] [Related]
5. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity
Boulete IM; Thadi A; Beaufrand C; Patwa V; Joshi A; Foss JA; Eddy EP; Eutamene H; Palejwala VA; Theodorou V; Shailubhai K
World J Gastroenterol; 2018 May; 24(17):1888-1900. PubMed ID: 29740204
[TBL] [Abstract][Full Text] [Related]
6. Multispecies probiotic protects gut barrier function in experimental models.
Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
[TBL] [Abstract][Full Text] [Related]
7. The comprehensive pathophysiological changes in a novel rat model of postinflammatory visceral hypersensitivity.
Ma J; Li J; Qian M; He N; Cao Y; Liu Y; Wu K; He S
FASEB J; 2019 Dec; 33(12):13560-13571. PubMed ID: 31570003
[TBL] [Abstract][Full Text] [Related]
8. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
[TBL] [Abstract][Full Text] [Related]
9. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway.
Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J
J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405
[TBL] [Abstract][Full Text] [Related]
10. Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats.
Qin HY; Xiao HT; Wu JC; Berman BM; Sung JJ; Bian ZX
World J Gastroenterol; 2012 May; 18(20):2481-92. PubMed ID: 22654445
[TBL] [Abstract][Full Text] [Related]
11. Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model.
Adam B; Liebregts T; Gschossmann JM; Krippner C; Scholl F; Ruwe M; Holtmann G
Pain; 2006 Jul; 123(1-2):179-86. PubMed ID: 16630696
[TBL] [Abstract][Full Text] [Related]
12. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
Nozu T; Arie H; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Int Immunopharmacol; 2024 May; 133():112099. PubMed ID: 38643709
[TBL] [Abstract][Full Text] [Related]
13. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
[TBL] [Abstract][Full Text] [Related]
14. Chronic colitis-induced visceral pain is associated with increased anxiety during quiescent phase.
Salameh E; Meleine M; Gourcerol G; do Rego JC; do Rego JL; Legrand R; Breton J; Aziz M; Guérin C; Coëffier M; Savoye G; Marion-Letellier R
Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G692-G700. PubMed ID: 30735453
[TBL] [Abstract][Full Text] [Related]
15. Elevated H2 O2 levels in trinitrobenzene sulfate-induced colitis rats contributes to visceral hyperalgesia through interaction with the transient receptor potential ankyrin 1 cation channel.
Kogure Y; Wang S; Tanaka K; Hao Y; Yamamoto S; Nishiyama N; Noguchi K; Dai Y
J Gastroenterol Hepatol; 2016 Jun; 31(6):1147-53. PubMed ID: 26574143
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
Silos-Santiago I; Hannig G; Eutamene H; Ustinova EE; Bernier SG; Ge P; Graul C; Jacobson S; Jin H; Liong E; Kessler MM; Reza T; Rivers S; Shea C; Tchernychev B; Bryant AP; Kurtz CB; Bueno L; Pezzone MA; Currie MG
Pain; 2013 Sep; 154(9):1820-1830. PubMed ID: 23748116
[TBL] [Abstract][Full Text] [Related]
18. Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model.
Song YF; Pei LX; Chen L; Geng H; Yuan MQ; Xu WL; Wu J; Zhou JY; Sun JH
Am J Chin Med; 2020; 48(1):77-90. PubMed ID: 31918565
[TBL] [Abstract][Full Text] [Related]
19. Colonic overexpression of the T-type calcium channel Ca
Scanzi J; Accarie A; Muller E; Pereira B; Aissouni Y; Goutte M; Joubert-Zakeyh J; Picard E; Boudieu L; Mallet C; Gelot A; Ardid D; Carvalho FA; Dapoigny M
Neurogastroenterol Motil; 2016 Nov; 28(11):1632-1640. PubMed ID: 27196538
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
Mao Y; Li Z; Chen K; Yu H; Zhang S; Jiang M; Ma Y; Liang C; Liu H; Li H; Hua Q; Zhou H; Sun Y; Fan X
Cell Physiol Biochem; 2017; 43(2):518-530. PubMed ID: 28930716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
